CoChat

Parenteral Calcitonin for Metabolic Bone Disease Associated With Primary Biliary Cirrhosis

Crosignani, Andrea, Battezzati, Pier Maria, Albisetti, Walter, Grandinetti, Giuseppe, Pietrogrande, Luca, Biffi, Arianna, Zuin, Massimo, Podda, Mauro · 1994 · Hepatology
Cited by 73

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

No satisfactory treatment is available for metabolic bone disease associated with primary biliary cirrhosis. On the basis of the similarities to postmenopausal osteoporosis, the rationale exists for calcitonin to be tested in clinical studies in patients with primary biliary cirrhosis—associated osteoporosis. We evaluated the effect of calcitonin on bone metabolism and mineral density in 25 women with primary biliary cirrhosis and severe osteopenia. After 6 mo of observation, patients received a synthetic calcitonin or a control treatment consisting of less than one hundredth of the recommended dose of porcine calcitonin. The two treatments were administered in sequence to each patient for two 6–mo periods, with a 3–mo washout between them, according to a crossover design. After the observation period, oral calcium supplementation was started. Bone mineral density was measured by dual–photon absorptiometry of the lumbar spine at study entry and at the beginning and the end of each treatment period. During the observation period bone mineral density fell by 3.5% whereas during the following 6 mo it increased in both the patients who received calcitonin (4.3%) and those who received the control treatment (4.9%). Conversely, after the crossover, bone mineral density decreased during both calcitonin (–2.7%) and control treatment (–2.9%). A significant difference was observed between the two periods but not between the two treatments or between the two sequences of treatment administration. In conclusion, our findings indicate that parenterally administered calcitonin for 6 mo is ineffective in halting bone loss in patients with primary biliary cirrhosis—associated metabolic bone disease, whereas calcium supplementation may have a transient beneficial effect. (Hepatology 1994;20:633-637).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.1840200313

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 31

  1. Hodgson, 1985, Ann Intern Med, 103, 855, 10.7326/0003-4819-103-6-855 · DOI · Paper page
  2. Almdal, 1989, J Intern Med, 225, 207, 10.1111/j.1365-2796.1989.tb00065.x · doi:10.1111/j.1365-2796.1989.tb00065.x
  3. Matloff, 1982, Gastroenterology, 83, 97, 10.1016/S0016-5085(82)80291-6 · DOI · Paper page
  4. Stellon, 1985, Q J Med, 223, 783
  5. Bone disease in patients with primary biliary cirrhosis. In: , eds. Progress in liver disease. Philadelphia: WB Saunders, 1990: 537–554.
  6. Stellon, 1987, Hepatology, 7, 137, 10.1002/hep.1840070127 · DOI · Paper page
  7. Mitchison, 1988, Gastroenterology, 94, 463, 10.1016/0016-5085(88)90438-6 · DOI
  8. Berg, 1992, Scand J Gastroenterol, 192, 43, 10.3109/00365529209095978 · DOI
  9. McDonald, 1991, Hepatology, 14, 613, 10.1002/hep.1840140407 · DOI · Paper page
  10. Wagonfeld, 1976, Lancet, 2, 391, 10.1016/S0140-6736(76)92407-7 · DOI
  11. Compston, 1979, Gut, 20, 133, 10.1136/gut.20.2.133 · DOI
  12. Davies, 1983, Dig Dis Sci, 28, 145, 10.1007/BF01315144 · DOI
  13. Herlong, 1982, Gastroenterology, 83, 103, 10.1016/S0016-5085(82)80292-8 · DOI · Paper page
  14. Arnaud, 1982, Gastroenterology, 83, 137, 10.1016/S0016-5085(82)80299-0 · DOI
  15. Gruber, 1984, Metabolism, 33, 295, 10.1016/0026-0495(84)90187-2 · DOI · Paper page
  16. MacIntyre, 1988, Lancet, 1, 900, 10.1016/S0140-6736(88)91712-6 · DOI · Paper page
  17. Reginster, 1991, Am J Med, 91, 19, 10.1016/0002-9343(91)90242-P · DOI
  18. Floreani, 1991, J Hepatol, 12, 217, 10.1016/0168-8278(91)90941-4 · DOI
  19. Camisasca, 1990, Hepatology, 12, 841
  20. Nuti, 1984, Calcif Tissue Int, 36, 76
  21. Mazzuoli, 1986, Calcif Tissue Int, 38, 3, 10.1007/BF02556587 · DOI · Paper page
  22. Wahner, 1985, Radiology, 156, 203, 10.1148/radiology.156.1.4001406 · DOI · Paper page
  23. Johnston, 1991, N Engl J Med, 324, 1105, 10.1056/NEJM199104183241606 · DOI · Paper page
  24. . Handbook of statistical tables. Reading, MA: Addison-Wesley, 1962.
  25. Rodysill, 1987, A review. J Chron Dis, 40, 743, 10.1016/0021-9681(87)90126-3 · DOI
  26. Prince, 1991, A comparative study of exercise, calcium supplementation and hormone-replacement therapy. N Engl J Med, 325, 1189
  27. Dawson-Hughes, 1990, N Engl J Med, 323, 878, 10.1056/NEJM199009273231305 · DOI · Paper page
  28. Heaney, 1991, Am J Med, 91, 23, 10.1016/0002-9343(91)90243-Q · DOI
  29. Sambrook, 1993, N Engl J Med, 328, 1747, 10.1056/NEJM199306173282404 · DOI · Paper page
  30. Bikle, 1983, Ann Intern Med, 98, 1013, 10.7326/0003-4819-98-6-1013 · DOI
  31. Storm, 1990, N Engl J Med, 322, 1265, 10.1056/NEJM199005033221803 · DOI · Paper page

Cited by

Metadata

Authors
Crosignani, A., Battezzati, P. M., Albisetti, W., Grandinetti, G., Pietrogrande, L., Biffi, A., Zuin, M., & Podda, M.
Venue
Hepatology
Published
1994-09
Volume
20
Issue
3
Pages
633-637
ISSN
0270-9139 (ISSN-L)
OpenAlex
W1996983302
Cited by
73
References
4
FWCI
0.68
Type
journal article
Language
en
Open access
closed
Licence
doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 7670 d)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.